Papers - ITOGA Mamichi
-
Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review.
Toshihiro Shiratori, Hisashi Tanaka, Chiori Tabe, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Shingo Takanashi, Sadatomo Tasaka
Thoracic cancer 11 ( 6 ) 1720 - 1723 2020.6
-
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer.
Hisashi Tanaka, Chiori Tabe, Fumihiko Okumura, Toshihiro Shiratori, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Takeshi Morimoto, Daisuke Kimura, Takao Tsushima, Sadatomo Tasaka
Thoracic cancer 11 ( 6 ) 1633 - 1638 2020.6
-
Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review.
Toshihiro Shiratori, Hisashi Tanaka, Chiori Tabe, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Shingo Takanashi, Sadatomo Tasaka
Thoracic cancer 11 ( 6 ) 1720 - 1723 2020.6
-
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab.
Kageaki Taima, Hisashi Tanaka, Masamichi Itoga, Yoshiko Ishioka, Akira Kurose, Sadatomo Tasaka
Respirology case reports 8 ( 5 ) e00580 - e00580 2020.5
-
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer
Tanaka H, Tabe C, Okumura F, Shiratori T, Ishioka Y, Itoga M, Taima K, Morimoto T, Kimura D, Tsushima T, Tasaka S.
Thorac Cancer 11 1633 - 1638 2020.4
-
繰り返す血胸・気胸を契機に診断された血管型Ehlers-Danlos症候群
石岡佳子，白鳥俊博，當麻景章，糸賀正道，林 周次郎，田坂定智
日呼吸誌 9 ( 6 ) 473 - 476 2020
-
Phase II trial of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer
Masamichi Itoga
Journal of Clinical Oncology 2020
-
A Case of Large Cell Neuroendocrine Carcinoma Successfully Treated with Nivolumab
Tabe Chiori, Tanaka Hisashi, Taima Kageaki, Itoga Masamichi, Shiratori Toshihiro, Tasaka Sadatomo
Haigan 59 ( 7 ) 1156 - 1161 2019.12
-
The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations.
Hiroaki Sakamoto, Hisashi Tanaka, Toshihiro Shiratori, Keisuke Baba, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Yukihiro Hasegawa, Shingo Takanashi, Sadatomo Tasaka
Molecular and clinical oncology 10 ( 6 ) 610 - 614 2019.6
-
The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations.
Hiroaki Sakamoto, Hisashi Tanaka, Toshihiro Shiratori, Keisuke Baba, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Yukihiro Hasegawa, Shingo Takanashi, Sadatomo Tasaka
Molecular and clinical oncology 10 ( 6 ) 610 - 614 2019.6
-
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer.
Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka, Keisuke Baba, Toshihiro Shiratori, Hiroaki Sakamoto, Junichiro Tsuchiya, Hideyuki Nakagawa, Yukihiro Hasegawa, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Medical oncology (Northwood, London, England) 36 ( 6 ) 57 - 57 2019.5
-
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer.
Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka, Keisuke Baba, Toshihiro Shiratori, Hiroaki Sakamoto, Junichiro Tsuchiya, Hideyuki Nakagawa, Yukihiro Hasegawa, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Medical oncology (Northwood, London, England) 36 ( 6 ) 57 - 57 2019.5
-
Efficacy of pembrolizumab for patients with both high PD-L1 expression and an MET exon 14 skipping mutation: A case report.
Keisuke Baba, Hisashi Tanaka, Hiroaki Sakamoto, Toshihiro Shiratori, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Sadatomo Tasaka
Thoracic cancer 10 ( 2 ) 369 - 372 2019.2
-
Efficacy of pembrolizumab for patients with both high PD-L1 expression and an MET exon 14 skipping mutation: A case report.
Keisuke Baba, Hisashi Tanaka, Hiroaki Sakamoto, Toshihiro Shiratori, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Sadatomo Tasaka
Thoracic cancer 10 ( 2 ) 369 - 372 2019.2
-
肺動脈と交通しmosaic attenuationを呈した縦隔型気管支動脈瘤
石岡佳子, 當麻景章, 糸賀正道, 坂本博昭, 掛端伸也, 田坂定智
日本呼吸器学会誌 8 ( 1 ) 72 - 75 2019
-
Emergency Radiotherapy for Spinal Cord Compression due to Bone Sarcoidosis.
Yoshihito Tanaka, Kageaki Taima, Hisashi Tanaka, Masamichi Itoga, Yoshiko Ishioka, Toshihiro Shiratori, Junichiro Tsuchiya, Hiroaki Sakamoto, Shingo Takanashi, Sadatomo Tasaka
Internal medicine (Tokyo, Japan) 57 ( 5 ) 717 - 720 2018.3
-
A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutations.
Hisashi Tanaka, Kageaki Taima, Yoshihito Tanaka, Masamichi Itoga, Yoshiko Ishioka, Hideyuki Nakagawa, Keisuke Baba, Yukihiro Hasegawa, Shingo Takanashi, Sadatomo Tasaka
Medical oncology (Northwood, London, England) 35 ( 3 ) 34 - 34 2018.2
-
Evaluating effectiveness of infection control efforts in hospitals using information in microbiological laboratory databases.
Norihiro Saito, Masamichi Itoga, Masahiko Kimura, Fumio Inoue, Satoko Minakawa, Toshiyuki Kimura, Hiromi Ozaki, Yumiko Saito, Mikiko Takahashi, Tetsuhiro Fujishima, Sumie Mizuno, Shin Ogawa, Yuko Kitayama, Kazumi Kudo, Kazushi Minami, Fumiko Abo, Yasuyuki Takano, Naotake Ohdaira, Satoshi Hamada, Shigeharu Ueki, Makoto Hirokawa, Hiroyuki Kayaba
Journal of general and family medicine 18 ( 6 ) 354 - 359 2017.12
-
A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer.
Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, Yoshihito Tanaka, Masamichi Itoga, Kunihiko Nakamura, Akihito Hayashi, Mika Kumagai, Hideo Yasugahira, Megumi Mikuniya, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
BMC cancer 17 ( 1 ) 683 - 683 2017.10
-
Regression of Crizotinib-Associated Complex Cystic Lesions after Switching to Alectinib.
Kageaki Taima, Hisashi Tanaka, Yoshihito Tanaka, Masamichi Itoga, Shingo Takanashi, Sadatomo Tasaka
Internal medicine (Tokyo, Japan) 56 ( 17 ) 2321 - 2324 2017.9